Polymeric delivery systems for the administration of therapeutic peptides and proteins;Formas farmacêuticas poliméricas para a administração de peptídeos e proteínas terapêuticos

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 33, Issue 4, 2012, Pages 469-477

  Melo, Cristiane da Silva ^a   Cunha Junior, Armando da Silva ^a   Fialho, Sílvia Ligório ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FUNDAÇÃO EZEQUIEL DIAS   (Brazil)

Author keywords

Controlled release; Polymeric systems; Protein

Indexed keywords

NANOPARTICLE; PEPTIDES AND PROTEINS;

ARTICLE; CHEMICAL MODIFICATION; DRUG DELIVERY SYSTEM; HYDROGEL; MACROMOLECULE;

EID: 84874693241     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Akagi T, Shima F, Akashi M. Intracellular degradation and distribution of protein-encapsulated amphiphilic poly(amino acid) nanoparticles. Biomaterials. 2011;32(21):4959-67.
2. Almeida AJ, Souto E. Solid lipid nanoparticles as drug delivery systems for peptides and proteins. Adv Drug Del Rev. 2007;59(6):478-90.
3. Appel EA, Loh XJ, Jones ST, Dreiss CA, Scherman OA. Sustained release of proteins from high water content supramolecular polymer hydrogels. Biomaterials. 2012;33(18):4646-52.
4. Benoit J, Marchais H, Rolland H, Velde VV. Biodegradable Microspheres: Advances in Production Technology. In: Benita S. Microencapsulation: methods and industrial applications. New York: Marcel Dekker Inc; 1996. chap. 3.
5. Berg JM, Tymoczko JL, Stryer L. Estrutura e Função das Proteínas. In: Berg JM, Tymoczko JL, Stryer L. Bioquímica. Rio de Janeiro: Guanabara Koogan; 2004. p. 124-139.
6. Bowey K, Swift BE, Flynn LE, Neufeld RJ. Characterization of biologically active insulin-loaded alginate microparticles prepared by spray drying. Drug Dev Ind Pharm. 2012. DOI:10.3109/03639045.2012.662985.
7. Buckel P. Recombinant proteins for therapy. Trends Pharmacol Sci. 1996;17(12):450-6.
8. Carrascosa C, Torres-Aleman I, Lopez-Lopez C, Carro E, Espejo L, Torrado S, Torrado JJ. Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration. Biomaterials. 2004;25(4):707-14
9. Cho HJ, Balakrishnan P, Chung SJ, Shim CK, Kim DD. Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery. Int J Pharm. 2011;416(1):77-84.
10. Dés Rieux A, Fievez V, Garinot M, Schneider Y, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release. 2006;116(1):1-27.
11. El-Sherbiny IM, Salama A, Sarhan AA. Ionotropically cross-linked pH-sensitive IPN hydrogel matrices as potential carriers for intestine-specific oral delivery of protein drugs. Drug Dev Ind Pharm. 2011;37(2):121-30.
12. Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov. 2005;4(4):298-306.
13. Geng Y, Yuan W, Wu F, Chen J, He M, Jin T. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release. 2008;130(3):259-65.
14. Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350(1-2):14-26.
15. Grabnar PA, Kristl J. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers. J Microencapsul. 2011;28(4):323-35.
16. Gregoriadis G, Jain S, Papaioannou I, Laing P. Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids. Int J Pharm. 2005;300(1-2):125-30.
17. Guerreiro LH, Da Silva D, Ricci-Junior E, Girard-Dias W, Mascarenhas CM, Sola-Penna M, Miranda K, Lima LM. Polymeric particles for the controlled release of human amylin. Colloids Surf B Biointerfaces. 2012;94:101-6.
18. Hoare TR, Kohane DS. Hydrogels in drug delivery: Progress and challenges. Polymer. 2008;49(8):1993-2007.
19. Jain AK, Khar RK, Ahmed FJ, Diwan PV. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier. Eur J Pharm Biopharm. 2008;69(2):426-35.
20. Jorgensen L, Moeller EH, Van de Weert M, Nielsen HM, Frokjaer S. Preparing and evaluating delivery systems for proteins. Eur J Pharm Sci. 2006;29(3-4):174-82.
21. Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P, Ravi Kumar MNV. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials. 2007;28(11):2051-2060.
22. Lee KY, Yuk SH. Polymeric protein delivery systems. Prog Polym Sci. 2007;32(7):669-97.
23. Liu Y, Lu W, Wang J, Zhang X, Zhang H, Wang X, Zhou T, Zhang Q. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic® F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization. J Control Release. 2007;117(3):387-95.
24. Lu XY, Wu DC, Li ZJ, Chen GQ. Polymer nanoparticles. Prog Mol Biol Transl Sci. 2011;104:299-323.
25. Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 2011;28:9-55.
26. McDowell A, McLeod BJ, Rades T, Tucker IG. Polymeric nanoparticles as an oral delivery system for biocontrol agents for the brushtail possum (Trichosurus vulpecula). N Z Vet J. 2009;57(6):370-7.
27. Biotechnology Medicines in Development. Research Promises to Bolster the Future of Medicine with More Than 900 Medicines and Vaccines in Development. 2011. [cited 2012 February 14]. Available from: http://www.phrma.org/sites/default/files/1776/biotech2011.pdf
28. Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Del Rev. 2001;47(2-3):165-96.
29. Melo CS, Pereira BG, Silva-Cunha A, Fialho SL. Poly-e-caprolactone microspheres containing interferon alpha as alternative formulations for the treatment of chronic hepatitis C. Braz J Pharm Sci. 2012;48(1). DOI: 10.1590/S1984-82502012000100006.
30. Moebus K, Siepman J, Bodmeier R. Novel preparation techniques for alginate poloxamer microparticles controlling protein release on mucosal surfaces. Eur J Pharm Sci. 2012;45(3):358-66.
31. Moeller EH, Jorgensen L. Alternative routes of administration for systemic delivery of protein pharmaceuticals. Drug Discov Today Technol. 2008;5(2-3):e89-e94.
32. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release. 2008;125(3):193-209.
33. Nelson DM, Ma Z, Leeson CE, Wagner WR. Extended and sequential delivery of protein from injectable thermoresponsive hydrogels. J Biomed Mater Res A. 2012;100(3):776-85.
34. Pescosolido L, Miatto S, Di Meo C, Cencetti C, Coviello T, Alhaique F, Matricardi P. Injectable and in situ gelling hydrogels for modified protein release. Eur Biophys J. 2010;39(6):903-909.
35. Prata, WM. Desenvolvimento de nanopartículas poliméricas carreadoras de proteínas como potenciais adjuvantes para uso em vacinas. [Dissertação]. Belo Horizonte: Faculdade de Farmácia, Universidade Federal de Minas Gerais; 2011.
36. Quintilio W, Takata CS, Sant'Anna OA, da Costa MH, Raw I. Evaluation of a diphtheria and tetanus PLGA microencapsulated vaccine formulation without stabilizers. Curr Drug Deliv. 2009;6(3):297-04.
37. Rafi M, Singh SM, Kanchan V, Anish CK, Panda AK. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles. J Microencapsul. 2010;27(6):552-60.
38. Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine. 2006;2(2):53-65.
39. Rosen H, Abribat T. The rise and rise of drug delivery. Nat Rev Drug Discov. 2005;4(5):381-5.
40. Santos RMM, Fialho SL. Nanopartículas: uma alternativa para a administração de biofármacos. Biotecnologia Cienc Desenvolv. 2007;37:52-9.
41. Saxena V, Naguib Y, Hussain MD. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer. Colloids Surf B Biointerfaces. 2012;1(94):274-80
42. Schaffazick SR, Guterres SS, Freitas LL, Pohlmann AF. Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos. Quim Nova. 2003;26(5):726-37.
43. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90(3):261-80.
44. Sokker HH, Abdel Ghaffar AM, Gad YH, Aly AS. Synthesis and characterization of hydrogels based on grafted chitosan for the controlled drug release. Carbohyd Polym. 2009;75(2):222-9.
45. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery - A promising option for orally less efficient drugs. J Control Release. 2006;114(1):15-40.
46. Teixeira M, Alonso MJ, Pinto MMM, Barbosa CM. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm. 2005;59(3):491-500.
47. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-88.
48. Wu Y, Wei W, Zhou M, Wang Y, Wu J, Ma G, Su Z. Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization. Biomaterials. 2012;33(7):2351-60.
49. Zhang X, Sun M, Zheng A, CAo D, Bi Y, Sun J. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Sci. 2012;45(5):632-8.